Weight loss injections work by mimicking two natural hormones in the gut: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1)
This transition has created new complexities for patients previously on compounded versions, as they must now obtain brand-name products through standard ePA channels, potentially increasing PA volume
reported LY3298176, a novel dual GIP and GLP-1R agonist for the treatment of type 2 diabetes, a study that demonstrated its potential from discovery to clinical proof-of-concept (Coskun et al., 2018)
[2] Clinical judgment should incorporate the patient's previous tolerance, reason for discontinuation, current metabolic status, and treatment goals
Contains Shellfish (Shrimp)
The liquid delivery format provides convenient daily performance and wellness support